In-Silico Studies toward the Improvement of the Antibacterial Activity of Pristinamycin IIB
Pristinamycin IIB (PIIB) is a potent antibiotic with limited use, due to some structural problems and also due to the bacterial resistance exhibited toward the antibiotic. A thorough study led to the design of novel analogues of PIIB, based on the introduction of a difluorostatone moiety. Herein, we...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Chemistry Proceedings |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4583/8/1/13 |